STOP ROP The STOP-ROP Multicenter Study Group: Pediatrics 105:295, 2000 Progression to Threshold Conventional Sat 89-94% STOP ROP

Size: px
Start display at page:

Download "STOP ROP The STOP-ROP Multicenter Study Group: Pediatrics 105:295, 2000 Progression to Threshold Conventional Sat 89-94% STOP ROP"

Transcription

1 Hrs TcPO2 > 80 nnhg (weeks 1 4) OXYGEN TARGETS: HOW GOOD ARE WE IN ACHIEVING THEM Oxygen Dependency GA wks Eduardo Bancalari MD University of Miami Miller School of Medicine Jackson Memorial Medical Center CARE OF THE SICK NEWBORN 2015 Postnatal age (weeks) Infants born at UM-JMH, GA 24-31w Years NONE MILD MODERATE-SEVERE Flynn J, Bancalari E, NEJM 1992 ROP Severity (N= 101) STOP ROP The STOP-ROP Multicenter Study Group: Pediatrics 105:295, 2000 Progression to Threshold Conventional Sat 89-94% Supplemental Sat 96-99% ALL 48% 41% Non plus disease OR 0.72 ( ) 46% 32% STOP ROP The STOP-ROP Multicenter Study Group: Pediatrics 105:295, 2000 Conventional Supplemental Pneumonia or Pulmonary Deterioration 8.5% 13.2% Hospitalized at 50 wks PMA 6.8% 12.7% On Oxygen at 50 wks PMA 37.0% 46.8% On Diuretics at 50 wks PMA 24.4% 35.8% 1

2 # of Desaturations (per week) BOOST TRIAL OUTCOME BPD (O2 at 36 weeks PMA) (%) Duration of oxygen therapy after randomization (Days /Median) Worst ROP (%) < Stage 3 Stage 3 or 4 Ablation Askie et al. NEJM Sept infants enrolled at 32 weeks PMA targets: vs Standard N=178 Bwt 918g High N=180 Bwt 916g 82 (46) 116 (64) < < (84) 28 (16) 20 (11) 158 (88) 22 (12) 11 (6) P Model Based Estimate of Desaturation Episodes in Infants with and without Laser Therapy for ROP Adjusted for gestational age, race, sex, multiples and SNAPPE-II Score LaserROP (n=16) No LaserROP (n=63) Postnatal Age (wks) p<.05 Mean± 95% confidence Interval J DiFiore, J Pediatr 2010 Lung tissue section (autopsy) from a term + 5 months child. Lung tissue section (biopsy) from an infant treated with prenatal steroids and postnatal surfactant born at 28 wks gestation and underwent an open lung biopsy 8-months after birth. Coalson JJ. Seminars in Neonatol, 2003; 8: Contrasting light microphotographs of lung parenchyma of RA and O 2 exposed rats. Shaffer SG et al. Pediatr Res, 1987; 21: Ten day old SD rats exposed to RA or O2 for 2-8 weeks Control RA OXYGEN AND THE BRAIN FiO2 0.8 Wilson WL et al. Pediatr Res, 1985; 19:

3 Distribution pattern, time, and age dependency of hyperoxia-induced apoptosis in infant rats Multivariate odds ratios for DCP with 95% CI and test of significance for risk factors Risk factor Model 1 (N=400) Model 2 (N=400) Model 3 (N=390) Model 4 (N=336) Cumulative hypocapnia 2.9 (1.6, 5.5) p= (1.1, 4.5) p= (1.0, 4.7) p= (1.1, 6.4) p= 0.03 Cumulative hyperoxemia 2.5 (1.3, 5.1) p= (1.1, 5.2) p= (0.9, 5.0) p= 0.10 Prolonged ventilation 2.9 (1.5, 5.6) p= (0.9, 5.9) p= (1.0, 8.9) p= 0.04 Gestational age 0.9 (0.6, 1.5) p= (0.7, 1.5) p= 0.59 Felderhoff-Mueser, U et al. Neurobiol Disease 2004; 17(2): From Collins, MP et al. Ped Res 2001; 50(6): Resuscitation of the Newly Born with Room Air or 100% O 2 Neonatal Death Term Preterm Odds Ratio Supplemental Oxygen for Preterm Infants: A Difficult Balancing Act CNS hypoxia-damage Multi organ/tissue hypoxia Pulmonary vasculature Ductus arteriosus Impaired growth Increased mortality? Lung injury-bpd Retinal damage-rop CNS damage Oxidative stress Increased mortality? Apgar score 1 min <4 Too Little Too Much Favoring 21% Favoring 100% Odds ratio and confidence intervals for neonatal death in term, preterm (>1,000g) and the most depressed infants (1-min Apgar <4). Odds ratio <1 indicates a favorable effect of 21% O2 compared with 100% O2. Saugstad OD et al. Biol Neonate 2005;87:27-34 SUPPORT Trial 1316 infants, weeks gestational age, O 2 saturation target 85%-89% vs 91%-95% ROP Lower O 2 Group n/n (%) Higher O 2 Group n/n (%) Adjusted Relative Risk (95% CI) Severe ROP 43/483 (8.9) 95/514 (18.5) 0.51 (0.37, 0.71) BPD (oxygen at 36 weeks) 203/540 (37.6) 265/568 (46.7) 0.82 (0.72, 0.93) BPD (physiologic) at 36 weeks 205/540 (38.0) 237/568 (41.7) 0.92 (0.81, 1.05) Death 130/654 (19.9) 107/662 (16.2) 1.27 (1.01, 1.60) SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network. N Engl J Med. 2010;362:

4 BPD NEC Mortality How good are we keeping oxygen targets? Achieved Versus Intended Pulse Oximeter in Infants Born Less Than 28wks The AVIOx Study Higher vs. Lower Arterial Oxygen s in Extremely Preterm Infants 14 Centers using different saturation targets Percent time Below target 16 (0-47) Within target 48 (6-75) Above target 36 (5-90) Hagadorn et al. Pediatrics 2006 Schmidt B et al. JAMA 2013; 309:

5 FiO2 SpO2 Why are we so bad in keeping oxygen targets? Blood oxygen level fluctuates constantly: Require continuous attendance and tight alarm settings Delayed response: Desensitization to frequent alarms Lack of buy-in by staff, unknown consequences of transient deviations More concern with hypoxemia than hyperoxemia Response not always appropriate for the mechanism of the hypoxemia Claure et al. J Pediatr 2009 Nurse: patient ratio and achievement of oxygen saturation goals in premature infants PaO 2 vs. SpO 2 Castillo et al, Pediatrics 2008 Quine et al, ADC FN Ed 2008 Sink DW, et al. Arch Dis Child Fetal Neonatal Ed (2010). Online First doi: /f2 of 6 adc How can maintenance of oxygen targets be improved? Develop clear unit guidelines for oxygen monitoring and targets Set alarms on target range Minimize factors that induce fluctuations in oxygenation Continuous education of medical and nursing personnel Proper nurse patient ratio Monitor incidence of pathologies associated with hyperoxia Automated systems for oxygen control Efficacy of Automated FiO2 Control % time within target Cl. loop Manual Type Beddis, 1979 Dugdale, 1988 Bhutani, 1992 Morozoff, 1992 Morozoff, 1993 Sun, 1997 Claure, 2001 Urschitz, 2004 Morozoff, 2009 Claure, 2009 Claure,

6 % of 24 hours Disclosure 50 Manual 40 Automated The University of Miami, Drs. Claure and Bancalari have a patent on the algorithm for automated adjustment of inspired oxygen and a licensing agreement with Carefusion Clio studies have been supported by Carefusion 10 0 < 75% < 87% 87-93% > 93% (@O2>21%) > 98% (@O2>21%) :p<0.001 Paired t-test (mean±sd) :p=0.003 Wilcoxon Signed Rank Test (median, IQR) SpO 2 Claure et al. PAS 2009 Prolonged episodes with SpO 2 below intended range Workload:FiO 2 adjustments SpO 2 < 85% (>120s) SpO 2 < 75% (>60s) Manual Automated Standard Automated :p<0.001 Paired t-test (mean±sd) :p<0.001 Paired t-test (mean±sd) :p=0.001 Wilcoxon Signed Rank Test (median and 25 th 75 th percentile) Claure et al. PAS 2009 Limitations Automated FiO 2 is dependent on pulse oximetry accuracy Observed differences in this study are relative to the effectiveness of the standard of care Automated FiO 2 should not substitute more appropriate interventions (e.g. in hypoventilation) Automated FiO 2 may give excessive sense of confidence and lead to reduce attentiveness 6

7 Oxygenation Targets: Can they be achieved? Surely can do better with oxygen targets, but Arterial oxygen levels fluctuate constantly in preterm infants and maintenance of targets is a tedious and demanding task Fluctuations can be produced by different mechanisms that require specific interventions While hypoxemic episodes are usually related to patient issues, hyperoxemia is always induced by excessive inspired oxygen Infants are seldom hyperoxic on room air Need to define the best targets and the short and long term consequences of fluctuations in oxygenation What oxygen targets should we use? Avoid hyperoxemia: Keep PaO2 <80 mmhg SpO2 under 95-97% Avoid hypoxemia: Keep PaO2>40mmHg SpO2 over 88-90% Keep higher SpO2 in infants with ROP or BPD? Keep in mind limitations of SpO2 in predicting PaO2 7

Disclosure COULD AUTOMATED CONTROL OF OXYGEN LEVELS IMPROVE SURVIVAL AND REDUCE NEC? Oxygen Dependency

Disclosure COULD AUTOMATED CONTROL OF OXYGEN LEVELS IMPROVE SURVIVAL AND REDUCE NEC? Oxygen Dependency COULD AUTOMATED CONTROL OF OXYGEN LEVELS IMPROVE SURVIVAL AND REDUCE NEC? Eduardo Bancalari MD University of Miami Miller School of Medicine Jackson Memorial Medical Center Sydney 206 Disclosure The University

More information

Rango de saturacion de oxigeno: Cual es la evidencia?

Rango de saturacion de oxigeno: Cual es la evidencia? Rango de saturacion de oxigeno: Cual es la evidencia? Wally Carlo, M.D. University of Alabama at Birmingham Department of Pediatrics Division of Neonatology wcarlo@peds.uab.edu 1 2 Stevie Wonder 4 Objectives

More information

Cover Page. The handle holds various files of this Leiden University dissertation

Cover Page. The handle   holds various files of this Leiden University dissertation Cover Page The handle http://hdl.handle.net/1887/46692 holds various files of this Leiden University dissertation Author: Zanten, Henriëtte van Title: Oxygen titration and compliance with targeting oxygen

More information

The SUPPORT, BOOST II, and COT Trials You Must Understand Usual Care To Safeguard Patients and Make Firm Conclusions

The SUPPORT, BOOST II, and COT Trials You Must Understand Usual Care To Safeguard Patients and Make Firm Conclusions The, BOOST II, and COT Trials You Must Understand Usual Care To Safeguard Patients and Make Firm Conclusions Charles Natanson M.D. Critical Care Medicine Department Clinical Center National Institutes

More information

FANNP 28TH NATIONAL NNP SYMPOSIUM: CLINICAL UPDATE AND REVIEW OCTOBER 17-21, 2017

FANNP 28TH NATIONAL NNP SYMPOSIUM: CLINICAL UPDATE AND REVIEW OCTOBER 17-21, 2017 Pulse Oximetry in the Delivery Room: Principles and Practice GS2 3 Jonathan P. Mintzer, MD, FAAP Assistant Professor of Pediatrics Stony Brook Children s Hospital, Division of Neonatal-Perinatal Medicine,

More information

Automated FiO 2 -SpO 2 control system in Neonates requiring respiratory support: a comparison of a standard to a narrow SpO 2 control range

Automated FiO 2 -SpO 2 control system in Neonates requiring respiratory support: a comparison of a standard to a narrow SpO 2 control range Wilinska et al. BMC Pediatrics 2014, 14:130 RESEARCH ARTICLE Open Access Automated FiO 2 -SpO 2 control system in Neonates requiring respiratory support: a comparison of a standard to a narrow SpO 2 control

More information

Objectives. Apnea Definition and Pitfalls. Pathophysiology of Apnea. Apnea of Prematurity and hypoxemia episodes 5/18/2015

Objectives. Apnea Definition and Pitfalls. Pathophysiology of Apnea. Apnea of Prematurity and hypoxemia episodes 5/18/2015 Apnea of Prematurity and hypoxemia episodes Deepak Jain MD Care of Sick Newborn Conference May 2015 Objectives Differentiating between apnea and hypoxemia episodes. Pathophysiology Diagnosis of apnea and

More information

Optimal Oxygenation of the Newborn

Optimal Oxygenation of the Newborn Optimal Oxygenation of the Newborn Ola Didrik Saugstad MD, PhD, FRCPE Department of Pediatric Research Oslo University Hospital, University of Oslo Norway 2 o Congreso Argentino de Neonatologia, Buenos

More information

GS3. Understanding How to Use Statistics to Evaluate an Article. Session Summary. Session Objectives. References. Session Outline

GS3. Understanding How to Use Statistics to Evaluate an Article. Session Summary. Session Objectives. References. Session Outline GS3 Understanding How to Use Statistics to Evaluate an Article Reese H. Clark, MD Director of Research Pediatrix Medical Group Neonatologist Greenville Memorial Hospital, Greenville, SC The speaker has

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Schmidt B, Whyte RK, Asztalos EV, et al; for the Canadian Oxygen Trial (COT) Group. Effects of targeting higher vs lower arterial oxygen saturations on death or disability

More information

1

1 1 2 3 RIFAI 5 6 Dublin cohort, retrospective review. Milrinone was commenced at an initial dose of 0.50 μg/kg/minute up to 0.75 μg/kg/minute and was continued depending on clinical response. No loading

More information

Minimizing Lung Damage During Respiratory Support

Minimizing Lung Damage During Respiratory Support Minimizing Lung Damage During Respiratory Support University of Miami Jackson Memorial Medical Center Care of the Sick Newborn 15 Eduardo Bancalari MD University of Miami Miller School of Medicine Jackson

More information

Reviews in Clinical Medicine

Reviews in Clinical Medicine Mashhad University of Medical Sciences (MUMS) Reviews in Clinical Medicine Clinical Research Development Center Ghaem Hospital The relation between oxygen saturation level and retionopathy of prematurity

More information

What s new in neonatal resuscitation?

What s new in neonatal resuscitation? What s new in neonatal resuscitation? Anup Katheria, M.D. Director, Neonatal Research Institute Sharp Mary Birch Hospital for Women & Newborns Disclosures I have no financial Disclosures. Overview Delivery

More information

Advance Pulse Oximetry: Settings, Data and Downloads

Advance Pulse Oximetry: Settings, Data and Downloads Advance Pulse Oximetry: Settings, Data and Downloads James I. Hagadorn MD, MS Assistant Professor of Pediatrics UCONN School of Medicine Attending Neonatologist Connecticut Children s Medical Center Hartford,

More information

Informed Consent for Standard of Care Research Interventions

Informed Consent for Standard of Care Research Interventions Informed Consent for Standard of Care Research Interventions Jeffrey R Botkin, MD, MPH Associate Vice President for Research A case Two FDA approved drugs are commonly used for the treatment of hypertension.

More information

USE OF INHALED NITRIC OXIDE IN THE NICU East Bay Newborn Specialists Guideline Prepared by P Joe, G Dudell, A D Harlingue Revised 7/9/2014

USE OF INHALED NITRIC OXIDE IN THE NICU East Bay Newborn Specialists Guideline Prepared by P Joe, G Dudell, A D Harlingue Revised 7/9/2014 USE OF INHALED NITRIC OXIDE IN THE NICU East Bay Newborn Specialists Guideline Prepared by P Joe, G Dudell, A D Harlingue Revised 7/9/2014 ino for Late Preterm and Term Infants with Severe PPHN Background:

More information

Patent Ductus Arteriosus: Philosophy or Pathology?

Patent Ductus Arteriosus: Philosophy or Pathology? Patent Ductus Arteriosus: Philosophy or Pathology? Disclosure Ray Sato, MD is a speaker for Prolacta Biosciences, Inc. This presentation will discuss off-label uses of acetaminophen and ibuprofen. RAY

More information

Oxygen targeting in preterm infants using the Masimo SET Radical pulse oximeter

Oxygen targeting in preterm infants using the Masimo SET Radical pulse oximeter 1 Simpson Centre for Reproductive Health, Royal Infi rmary of Edinburgh, Edinburgh, UK 2 National Perinatal Epidemiology Unit, University of Oxford, Oxford, UK Correspondence to Dr B J Stenson, Simpson

More information

Surfactant Administration

Surfactant Administration Approved by: Surfactant Administration Gail Cameron Senior Director Operations, Maternal, Neonatal & Child Health Programs Dr. Paul Byrne Medical Director, Neonatology Neonatal Policy & Procedures Manual

More information

Avoiding hyperoxia in infants p1250 g is associated with improved short- and long-term outcomes

Avoiding hyperoxia in infants p1250 g is associated with improved short- and long-term outcomes (2006) 26, 700 705 r 2006 Nature Publishing Group All rights reserved. 0743-8346/06 $30 www.nature.com/jp ORIGINAL ARTICLE Avoiding hyperoxia in infants p1250 g is associated with improved short- and long-term

More information

Edinburgh Research Explorer

Edinburgh Research Explorer Edinburgh Research Explorer Oxygen targeting in preterm infants using the Masimo SET Radical pulse oximeter Citation for published version: Johnston, ED, Boyle, B, Juszczak, E, King, A, Brocklehurst, P

More information

Best Practices in Bronchopulmonary

Best Practices in Bronchopulmonary Best Practices in Bronchopulmonary Dysplasia a (BPD) Prevention e Matthew M. Laughon, MD, MPH Professor of Pediatrics The University of North Carolina at Chapel Hill I receive support from the U.S. government

More information

Bronchopulmonary dysplasia: incidence and risk factors

Bronchopulmonary dysplasia: incidence and risk factors Original article Arch Argent Pediatr 2017;115(5):476-482 / 476 Bronchopulmonary dysplasia: incidence and risk factors Pablo H. Brener Dik, M.D. a, Yeimy M. Niño Gualdron, M.D. a, María F. Galletti, M.D.

More information

The Oxygen Controversy Why can t Neonatologists get it Correct?

The Oxygen Controversy Why can t Neonatologists get it Correct? The Oxygen Controversy Why can t Neonatologists get it Correct? Richard A. Polin M.D. Morgan Stanley Children s Hospital Columbia University Cyanophobia Blue Objectives To review the benefits and risks

More information

Gestational age-adapted oxygen saturation targeting and outcome of extremely low gestational age neonates (ELGANs)

Gestational age-adapted oxygen saturation targeting and outcome of extremely low gestational age neonates (ELGANs) Published 2 November 2015, doi:10.4414/smw.2015.14197 Cite this as: Gestational age-adapted oxygen saturation targeting and outcome of extremely low gestational age neonates (ELGANs) A Swiss single centre

More information

Oxygen Delivery. Purpose. Policy Statement. Applicability

Oxygen Delivery. Purpose. Policy Statement. Applicability Approved by: Oxygen Delivery Gail Cameron Senior Director Operations, Maternal, Neonatal & Child Health Programs Dr. Paul Byrne Medical Director, Neonatology Neonatal Policy & Procedures Manual Policy

More information

Using Nightingale to Identify Opportunities for Improvement

Using Nightingale to Identify Opportunities for Improvement Using Nightingale to Identify Opportunities for Improvement Erika M. Edwards PhD, MPH Director of Data Systems and Analytics Vermont Oxford Network Research Assistant Professor Mathematics and Statistics

More information

Automatic Control of the Inspired Oxygen Fraction in Preterm Infants A Randomized Crossover Trial

Automatic Control of the Inspired Oxygen Fraction in Preterm Infants A Randomized Crossover Trial Automatic Control of the Inspired Oxygen Fraction in Preterm Infants A Randomized Crossover Trial Michael S. Urschitz, Werner Horn, Andreas Seyfang, Antonella Hallenberger, Tina Herberts, Silvia Miksch,

More information

CPAP failure in preterm infants: incidence, predictors and consequences

CPAP failure in preterm infants: incidence, predictors and consequences CPAP failure in preterm infants: incidence, predictors and consequences SUPPLEMENTAL TEXT METHODS Study setting The Royal Hobart Hospital has an 11-bed combined Neonatal and Paediatric Intensive Care Unit

More information

target groups. The collective data suggest that risks associated with restricting the upper SpO 2

target groups. The collective data suggest that risks associated with restricting the upper SpO 2 Oxygen Saturation Targets in Preterm Infants and Outcomes at 18 24 Months: A Systematic Review Veena Manja, MD, MS, a, b Ola D. Saugstad, MD, PhD, c Satyan Lakshminrusimha, MD, FAAP d CONTEXT: The optimal

More information

Title of Program: Preventing and Treating Retinopathy of Prematurity: Evidence from Cochrane Systematic Reviews

Title of Program: Preventing and Treating Retinopathy of Prematurity: Evidence from Cochrane Systematic Reviews Title of Program: Preventing and Treating Retinopathy of Prematurity: Evidence from Cochrane Systematic Reviews Speakers/Moderators: Roger F. Soll, MD, James Hagadorn, MD Planning Committee: Jeffery D.

More information

NEONATAL CLINICAL PRACTICE GUIDELINE

NEONATAL CLINICAL PRACTICE GUIDELINE NEONATAL CLINICAL PRACTICE GUIDELINE Title: Brain Oxygen Monitoring in Newborns Using Near Infrared Spectroscopy (NIRS) Approval Date: Pages: June 2016 Approved by: Neonatal Patient Care Teams, HSC & SBH

More information

Update on mangement of patent ductus arteriosus in preterm infants. Dr. Trinh Thi Thu Ha

Update on mangement of patent ductus arteriosus in preterm infants. Dr. Trinh Thi Thu Ha Update on mangement of patent ductus arteriosus in preterm infants Dr. Trinh Thi Thu Ha Outline 1. Overview of PDA 2. Timing of screening PDA? 3. When to treat PDA? Timing of ductal closure Prenatal

More information

Presented By : Kamlah Olaimat

Presented By : Kamlah Olaimat Presented By : Kamlah Olaimat 18\7\2010 Transient Tachpnea of the Definition:- newborn (TTN) TTN is a benign disease of near term or term infant who display respiratory distress shortly after delivery.

More information

Hazards and Benefits of Postnatal Steroids. David J. Burchfield, MD Professor and Chief, Neonatology University of Florida

Hazards and Benefits of Postnatal Steroids. David J. Burchfield, MD Professor and Chief, Neonatology University of Florida Hazards and Benefits of Postnatal Steroids David J. Burchfield, MD Professor and Chief, Neonatology University of Florida Disclosures I have no financial affiliations or relationships to disclose. I will

More information

An Update on Caffeine Therapy

An Update on Caffeine Therapy An Update on Caffeine Therapy Emory University School of Medicine Atlanta, GA Wally Carlo, MD University of Alabama at Birmingham Department of Pediatrics Division of Neonatology wcarlo@peds.uab.edu Objectives

More information

Prevention of retinopathy of prematurity in preterm infants through changes in clinical practice and SpO 2 technology

Prevention of retinopathy of prematurity in preterm infants through changes in clinical practice and SpO 2 technology Acta Pædiatrica ISSN 0803 5253 REGULAR ARTICLE Prevention of retinopathy of prematurity in preterm infants through changes in clinical practice and SpO 2 technology Armando Castillo 1, Richard Deulofeut

More information

Noah Hillman M.D. IPOKRaTES Conference Guadalajaira, Mexico August 23, 2018

Noah Hillman M.D. IPOKRaTES Conference Guadalajaira, Mexico August 23, 2018 Postnatal Steroids Use for Bronchopulmonary Dysplasia in 2018 + = Noah Hillman M.D. IPOKRaTES Conference Guadalajaira, Mexico August 23, 2018 AAP Policy Statement - 2002 This statement is intended for

More information

Bubble CPAP for Respiratory Distress Syndrome in Preterm Infants

Bubble CPAP for Respiratory Distress Syndrome in Preterm Infants R E S E A R C H P A P E R Bubble CPAP for Respiratory Distress Syndrome in Preterm Infants JAGDISH KOTI*, SRINIVAS MURKI, PRAMOD GADDAM, ANUPAMA REDDY AND M DASARADHA RAMI REDDY From Fernandez Hospital

More information

Advanced Monitoring of Cardiovascular and Respiratory Systems in Infants Kuwait 2018 Dr. Yasser Elsayed, MD, PhD Director of the Targeted Neonatal

Advanced Monitoring of Cardiovascular and Respiratory Systems in Infants Kuwait 2018 Dr. Yasser Elsayed, MD, PhD Director of the Targeted Neonatal Advanced Monitoring of Cardiovascular and Respiratory Systems in Infants Kuwait 2018 Dr. Yasser Elsayed, MD, PhD Director of the Targeted Neonatal Echocardiography, Point of Care and Hemodynamics Program

More information

Original Policy Date

Original Policy Date MP 8.01.17 Inhaled Nitric Oxide Medical Policy Section Therapy Issue 12/2013 Original Policy Date 12/2013 Last Review Status/Date Reviewed with literature search/12/2013 Return to Medical Policy Index

More information

Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity (STOP-ROP), A Randomized, Controlled Trial. I: Primary Outcomes

Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity (STOP-ROP), A Randomized, Controlled Trial. I: Primary Outcomes PEDIATRICS Feb 2000 VOL. 105 NO. 2 Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity (STOP-ROP), A Randomized, Controlled Trial. I: Primary Outcomes The STOP-ROP Multicenter Study

More information

Saturation Targets Are They Achievable? Preventing Intermittent Hypoxemia

Saturation Targets Are They Achievable? Preventing Intermittent Hypoxemia Saturation Targets Are They Achievable? Preventing Intermittent Hypoxemia Professor and Chief Department of Neonatology Tuebingen University Hospital Prof. Poets graduated from Hannover Medical School

More information

The Objective Use of Pulse Oximetry to Predict Respiratory Support Transition in Preterm Infants: An Observational Pilot Study

The Objective Use of Pulse Oximetry to Predict Respiratory Support Transition in Preterm Infants: An Observational Pilot Study The Objective Use of Pulse Oximetry to Predict Respiratory Support Transition in Preterm Infants: An Observational Pilot Study Kemi K Mascoll-Robertson MBBS, Rose M Viscardi MD, and Hyung C Woo MD BACKGROUND:

More information

Name and title of the investigators responsible for conducting the research: Dr Anna Lavizzari, Dr Mariarosa Colnaghi

Name and title of the investigators responsible for conducting the research: Dr Anna Lavizzari, Dr Mariarosa Colnaghi Protocol title: Heated, Humidified High-Flow Nasal Cannula vs Nasal CPAP for Respiratory Distress Syndrome of Prematurity. Protocol identifying number: Clinical Trials.gov NCT02570217 Name and title of

More information

AEROSURF Phase 2 Program Update Investor Conference Call

AEROSURF Phase 2 Program Update Investor Conference Call AEROSURF Phase 2 Program Update Investor Conference Call November 12, 2015 Forward Looking Statement To the extent that statements in this presentation are not strictly historical, including statements

More information

Neonatal Resuscitation in What is new? How did we get here? Steven Ringer MD PhD Harvard Medical School May 25, 2011

Neonatal Resuscitation in What is new? How did we get here? Steven Ringer MD PhD Harvard Medical School May 25, 2011 Neonatal Resuscitation in 2011- What is new? How did we get here? Steven Ringer MD PhD Harvard Medical School May 25, 2011 Conflicts I have no actual or potential conflict of interest in relation to this

More information

Respiratory Management and Outcome of Preterm Infants

Respiratory Management and Outcome of Preterm Infants Respiratory Management and Outcome of Preterm Infants 6 th Annual Care Of The Sick Newborn Conference Shu Wu, MD. Department of Pediatrics Division of Neonatology University of Miami School of Medicine

More information

Steven Ringer MD PhD April 5, 2011

Steven Ringer MD PhD April 5, 2011 Steven Ringer MD PhD April 5, 2011 Disclaimer Mead Johnson sponsors programs such as this to give healthcare professionals access to scientific and educational information provided by experts. The presenter

More information

Hyaline membrane disease. By : Dr. Ch Sarishma Peadiatric Pg

Hyaline membrane disease. By : Dr. Ch Sarishma Peadiatric Pg Hyaline membrane disease By : Dr. Ch Sarishma Peadiatric Pg Also called Respiratory distress syndrome. It occurs primarily in premature infants; its incidence is inversely related to gestational age and

More information

Oxygen Targeting in Extremely Low Birth Weight Infants James J. Cummings, MD, FAAP, Richard A. Polin, MD, FAAP, COMMITTEE ON FETUS AND NEWBORN

Oxygen Targeting in Extremely Low Birth Weight Infants James J. Cummings, MD, FAAP, Richard A. Polin, MD, FAAP, COMMITTEE ON FETUS AND NEWBORN CLINICAL REPORT Guidance for the Clinician in Rendering Pediatric Care Oxygen Targeting in Extremely Low Birth Weight Infants James J. Cummings, MD, FAAP, Richard A. Polin, MD, FAAP, COMMITTEE ON FETUS

More information

BRONCHOPULMONARY DYSPLASIA

BRONCHOPULMONARY DYSPLASIA BRONCHOPULMONARY DYSPLASIA CHRONIC NEONATAL LUNG DISEASE (CLD) 2 2 nd BERLIN NEONATOLOGY SUMMER SCHOOL September 2014 3 Mt. Scopus 4 Ein Kerem 5 BRONCHOPULMONARY DYSPLASIA 1960: Ventilation of Neonates

More information

Research Article Timing of Caffeine Therapy and Neonatal Outcomes in Preterm Infants: A Retrospective Study

Research Article Timing of Caffeine Therapy and Neonatal Outcomes in Preterm Infants: A Retrospective Study International Pediatrics Volume 2016, Article ID 9478204, 6 pages http://dx.doi.org/10.1155/2016/9478204 Research Article Timing of Caffeine Therapy and Neonatal Outcomes in Preterm Infants: A Retrospective

More information

Post Arrest Ventilation/Oxygenation Management

Post Arrest Ventilation/Oxygenation Management Post Arrest Ventilation/Oxygenation Management Richard Branson MSc RRT Professor of Surgery University of Cincinnati Editor-In-Chief Respiratory Care 0 Presenter Disclosure Information Richard Branson

More information

Management of Post Cardiac Arrest Syndrome

Management of Post Cardiac Arrest Syndrome Management of Post Cardiac Arrest Syndrome Wilhelm Behringer Associated Professor of Emergency Medicine Medical University of Vienna, Austria Patients % What happens after ROSC? 35 30 25 20 15 10 5 ROSC

More information

The Role of Oxygen in Health and Disease - A Series of Reviews

The Role of Oxygen in Health and Disease - A Series of Reviews 0031-3998/09/6504-0375 PEDIATRIC RESEARCH Copyright 2009 International Pediatric Research Foundation, Inc. Vol. 65, No. 4, 2009 Printed in U.S.A. The Role of Oxygen in Health and Disease - A Series of

More information

Oxygen Saturation Target Range for Extremely Preterm Infants A Systematic Review and Meta-analysis

Oxygen Saturation Target Range for Extremely Preterm Infants A Systematic Review and Meta-analysis Research Original Investigation Saturation Target Range for Extremely Preterm Infants A Systematic Review and Meta-analysis Veena Manja, MD; Satyan Lakshminrusimha, MD; Deborah J. Cook, MSc, MD IMPORTANCE

More information

King s Research Portal

King s Research Portal King s Research Portal DOI: 10.1007/s00431-015-2595-4 Document Version Peer reviewed version Link to publication record in King's Research Portal Citation for published version (APA): Shetty, S., Bhat,

More information

ROLE OF EARLY POSTNATAL DEXAMETHASONE IN RESPIRATORY DISTRESS SYNDROME

ROLE OF EARLY POSTNATAL DEXAMETHASONE IN RESPIRATORY DISTRESS SYNDROME INDIAN PEDIATRICS VOLUME 35-FEBRUAKY 1998 ROLE OF EARLY POSTNATAL DEXAMETHASONE IN RESPIRATORY DISTRESS SYNDROME Kanya Mukhopadhyay, Praveen Kumar and Anil Narang From the Division of Neonatology, Department

More information

Research in Medical Physics: Physiological Signals and Dynamics

Research in Medical Physics: Physiological Signals and Dynamics Research in Medical Physics: Physiological Signals and Dynamics Incidents of apnea or of sepsis create critical situations in a neonatal intensive care unit (NICU). Of the 4.2 million babies born annually

More information

Von Reuss and CPAP, Disclosures CPAP. Noninvasive respiratory therapieswhy bother? Noninvasive respiratory therapies- types

Von Reuss and CPAP, Disclosures CPAP. Noninvasive respiratory therapieswhy bother? Noninvasive respiratory therapies- types Noninvasive respiratory therapiesby a nose? NEO- The Conference for Neonatology February 21, 2014 Disclosures I have no relevant financial relationships to disclose or conflicts of interest to release.

More information

Quality Improvement Approaches to BPD. Jay P. Goldsmith, M.D. Tulane University New Orleans, Louisiana

Quality Improvement Approaches to BPD. Jay P. Goldsmith, M.D. Tulane University New Orleans, Louisiana Quality Improvement Approaches to BPD Jay P. Goldsmith, M.D. Tulane University New Orleans, Louisiana goldsmith.jay@gmail.com No conflicts of interest to declare There is nothing more dangerous to the

More information

Clinical Prediction Score for Nasal CPAP Failure in Pre-term VLBW Neonates with Early Onset Respiratory Distress

Clinical Prediction Score for Nasal CPAP Failure in Pre-term VLBW Neonates with Early Onset Respiratory Distress JOURNAL OF TROPICAL PEDIATRICS, VOL. 57, NO. 4, 2011 Clinical Prediction Score for Nasal CPAP Failure in Pre-term VLBW Neonates with Early Onset Respiratory Distress by Mrinal S. Pillai, 1 Mari J. Sankar,

More information

B ronchopulmonary dysplasia (BPD) is an inflammatory

B ronchopulmonary dysplasia (BPD) is an inflammatory ORIGINAL ARTICLE Does the use of at birth in preterm infants reduce lung injury? A E Harling, M W Beresford, G S Vince, M Bates, C W Yoxall... See end of article for authors affiliations... Correspondence

More information

Disclosures. Learning Objectives. Mechanical Ventilation of Infants with Severe BPD: An Interdisciplinary Approach 3/10/2017

Disclosures. Learning Objectives. Mechanical Ventilation of Infants with Severe BPD: An Interdisciplinary Approach 3/10/2017 Mechanical Ventilation of Infants with Severe BPD: An Interdisciplinary Approach Steven H. Abman, MD Professor, Department of Pediatrics Director, Pediatric Heart Lung Center University of Colorado School

More information

An Overview of Bronchopulmonary Dysplasia and Chronic Lung Disease in Infancy

An Overview of Bronchopulmonary Dysplasia and Chronic Lung Disease in Infancy An Overview of Bronchopulmonary Dysplasia and Chronic Lung Disease in Infancy Housekeeping: I have no financial disclosures Learning objectives: Develop an understanding of bronchopulmonary dysplasia (BPD)

More information

Short-Term Outcome Of Different Treatment Modalities Of Patent Ductus Arteriosus In Preterm Infants. Five Years Experiences In Qatar

Short-Term Outcome Of Different Treatment Modalities Of Patent Ductus Arteriosus In Preterm Infants. Five Years Experiences In Qatar ISPUB.COM The Internet Journal of Cardiovascular Research Volume 7 Number 2 Short-Term Outcome Of Different Treatment Modalities Of Patent Ductus Arteriosus In Preterm Infants. Five Years Experiences In

More information

Satellite Symposium. Sponsored by

Satellite Symposium. Sponsored by Satellite Symposium Sponsored by Management of fluids and electrolytes in the preterm infant in the first week of life Pam Cairns St Michaels Hospital Bristol Healthy, term, breast fed babies Limited intake

More information

SARASOTA MEMORIAL HOSPITAL NURSING PROCEDURE

SARASOTA MEMORIAL HOSPITAL NURSING PROCEDURE SARASOTA MEMORIAL HOSPITAL TITLE: NURSING PROCEDURE Management, Monitoring & Documentation of a Clinically Significant Cardiopulmonary Event (CSCPE) (NUR47) DATE: REVIEWED: PAGES: 9/09 9/17 1 of 6 PS1094

More information

Predicting Mortality and Intestinal Failure in Neonates with Surgical Necrotizing Enterocolitis

Predicting Mortality and Intestinal Failure in Neonates with Surgical Necrotizing Enterocolitis Predicting Mortality and Intestinal Failure in Neonates with Surgical Necrotizing Enterocolitis Darshna Bhatt MHA DO, Curtis Travers MPH, Ravi M. Patel MD MSc, Julia Shinnick MD, Kelly Arps MD, Sarah Keene,

More information

Neonatal Resuscitation Using a Nasal Cannula: A Single-Center Experience

Neonatal Resuscitation Using a Nasal Cannula: A Single-Center Experience Original Article Neonatal Resuscitation Using a Nasal Cannula: A Single-Center Experience Pedro Paz, MD, MPH 1 Rangasamy Ramanathan, MD 1,2 Richard Hernandez, RCP 2 Manoj Biniwale, MD 1 1 Division of Neonatal

More information

Home Cardiorespiratory Monitoring. Description. Section: Durable Medical Equipment Effective Date: April 15, 2017

Home Cardiorespiratory Monitoring. Description. Section: Durable Medical Equipment Effective Date: April 15, 2017 Subject: Home Cardiorespiratory Monitoring Page: 1 of 9 Last Review Status/Date: March 2017 Home Cardiorespiratory Monitoring Description Home cardiorespiratory monitors track respiratory effort and heart

More information

Non Invasive Ventilation In Preterm Infants. Manuel Sanchez Luna Hospital General Universitario Gregorio Marañón Complutense University Madrid

Non Invasive Ventilation In Preterm Infants. Manuel Sanchez Luna Hospital General Universitario Gregorio Marañón Complutense University Madrid Non Invasive Ventilation In Preterm Infants Manuel Sanchez Luna Hospital General Universitario Gregorio Marañón Complutense University Madrid Summary Noninvasive ventilation begings in the delivery room

More information

Perioperative Use of Oxygen: What is the Right Amount?

Perioperative Use of Oxygen: What is the Right Amount? Perioperative Use of Oxygen: What is the Right Amount? Walid Habre, MD, PhD Anesthesiological Investigations Unit & Pediatric Anesthesia Unit Geneva University Hospitals and University of Geneva www.walidhabre.org

More information

Kugelman A, Riskin A, Said W, Shoris I, Mor F, Bader D.

Kugelman A, Riskin A, Said W, Shoris I, Mor F, Bader D. Heated, Humidified High-Flow Nasal Cannula (HHHFNC) vs. Nasal Intermittent Positive Pressure Ventilation (NIPPV) for the Primary Treatment of RDS, A Randomized, Controlled, Prospective, Pilot Study Kugelman

More information

King s Research Portal

King s Research Portal King s Research Portal DOI: 10.1007%2Fs00431-015-2595-4 Document Version Peer reviewed version Link to publication record in King's Research Portal Citation for published version (APA): Shetty, S., Bhat,

More information

N orthway et first described bronchopulmonary

N orthway et first described bronchopulmonary F6 ORIGINAL ARTICLE Does sustained lung inflation at resuscitation reduce lung injury in the preterm infant? A E Harling, M W Beresford, G S Vince, M Bates, C W Yoxall... See end of article for authors

More information

Earlier Use of Inhaled Nitric Oxide in Term and Near-Term Neonates With Hypoxic Respiratory Failure (HRF) and Pulmonary Hypertension (PH)

Earlier Use of Inhaled Nitric Oxide in Term and Near-Term Neonates With Hypoxic Respiratory Failure (HRF) and Pulmonary Hypertension (PH) Earlier Use of Inhaled Nitric Oxide in Term and Near-Term Neonates With Hypoxic Respiratory Failure (HRF) and Pulmonary Hypertension (PH) 2013 Ikaria, Inc. 1 Disclosure Information This program is sponsored

More information

Nutrition of preterm infants in relation to bronchopulmonary dysplasia

Nutrition of preterm infants in relation to bronchopulmonary dysplasia RESEARCH ARTICLE Nutrition of preterm infants in relation to bronchopulmonary dysplasia Andreas Wemhöner 1,2*, Daniel Ortner 1, Edda Tschirch 1,2, Alexander Strasak 3, Mario Rüdiger 1,2 Open Access Background:

More information

Accuracy of Pulse Oximetry in Children

Accuracy of Pulse Oximetry in Children Accuracy of Pulse Oximetry in Children WHAT S KNOWN ON THIS SUBJECT: Saturations from pulse oximetry (SpO 2 ) may overestimate arterial oxygen saturations measured by CO-oximetry (SaO 2 ). The overestimation

More information

Stabilization and Transportation guidelines for Neonates and infants with Heart disease:

Stabilization and Transportation guidelines for Neonates and infants with Heart disease: Stabilization and Transportation guidelines for Neonates and infants with Heart disease: Background: Referral Pediatric Cardiac Units, frequently receive neonates and infants referred and transported from

More information

Pulse Oximetry in Comparison to Arterial Blood Oxygen Saturation in Respiratory Distress in Neonates

Pulse Oximetry in Comparison to Arterial Blood Oxygen Saturation in Respiratory Distress in Neonates Pulse Oximetry in Comparison to Arterial Blood Oxygen Saturation in Respiratory Distress in Neonates Samiha Samuel Wissa Doss, Dalia Sayed Mosallam, Enas Abdallah Ali, Marwa Mohamed Mohamed Moro Departments

More information

COMPARISON OF THE EFFICIENCY OF CAFFEINE VERSUS AMINOPHYLLINE FOR THE TREATMENT OF APNOEA OF PREMATURITY

COMPARISON OF THE EFFICIENCY OF CAFFEINE VERSUS AMINOPHYLLINE FOR THE TREATMENT OF APNOEA OF PREMATURITY CASE STUDIES COMPARISON OF THE EFFICIENCY OF CAFFEINE VERSUS AMINOPHYLLINE FOR THE TREATMENT OF APNOEA OF PREMATURITY Gabriela Ildiko Zonda 1, Andreea Avasiloaiei 1, Mihaela Moscalu 2, Maria Stamatin 1

More information

DISCLOSURE FUNDING BRONCHOPULMONARY DYPLASIA (BPD) UCSF. Preventing BPD: Is Inhaled Nitric Oxide the Answer? March, 2009

DISCLOSURE FUNDING BRONCHOPULMONARY DYPLASIA (BPD) UCSF. Preventing BPD: Is Inhaled Nitric Oxide the Answer? March, 2009 Preventing BPD: Is Inhaled Nitric Oxide the Answer? March, 2009 Roberta A. Ballard Professor of Pediatrics UCSF DISCLOSURE INO THERAPEUTICS (IKARIA) has provided: * Inhaled Nitric Oxide (INOmax) * Delivery

More information

Late pulmonary hypertension in preterm infants How to sort things out? V.Gournay, FCPC, La Martinique, Nov 23,2015

Late pulmonary hypertension in preterm infants How to sort things out? V.Gournay, FCPC, La Martinique, Nov 23,2015 Late pulmonary hypertension in preterm infants How to sort things out? V.Gournay, FCPC, La Martinique, Nov 23,2015 Epidemiology Incidence of extreme prematurity (

More information

Neonatal/Pediatric Cardiopulmonary Care. Persistent Pulmonary Hypertension of the Neonate (PPHN) PPHN. Other. Other Diseases

Neonatal/Pediatric Cardiopulmonary Care. Persistent Pulmonary Hypertension of the Neonate (PPHN) PPHN. Other. Other Diseases Neonatal/Pediatric Cardiopulmonary Care Other Diseases Persistent Pulmonary Hypertension of the Neonate (PPHN) PPHN 3 Also known as Persistent Fetal Circulation (PFC) Seen most frequently in term, post-term

More information

SURFACTANT UPDATE. George Mandy, M.D. Nationwide Children s Hospital The Ohio State University

SURFACTANT UPDATE. George Mandy, M.D. Nationwide Children s Hospital The Ohio State University SURFACTANT UPDATE George Mandy, M.D. Nationwide Children s Hospital The Ohio State University Surfactant Update Objectives History Meta-analysis of surfactant therapy New synthetic surfactant Genetic disorders

More information

MEDICAL POLICY I. POLICY POLICY TITLE POLICY NUMBER INHALED NITRIC OXIDE MP-4.021

MEDICAL POLICY I. POLICY POLICY TITLE POLICY NUMBER INHALED NITRIC OXIDE MP-4.021 Original Issue Date (Created): August 23, 2002 Most Recent Review Date (Revised): January 28, 2014 Effective Date: April 1, 2014 I. POLICY Inhaled nitric oxide may be considered medically necessary as

More information

PATENT DUCTUS ARTERIOSUS IN THE PRETERM INFANT EVIDENCE FOR & AGAINST TREATMENT

PATENT DUCTUS ARTERIOSUS IN THE PRETERM INFANT EVIDENCE FOR & AGAINST TREATMENT PATENT DUCTUS ARTERIOSUS IN THE PRETERM INFANT EVIDENCE FOR & AGAINST TREATMENT Dr. Youssef Abou Zanouna, FRCPI, FACC Consultant Pediatric Cardiologist King Fahd Military Medical Complex Dhahran Introduction

More information

Blood transfusion and intestinal perfusion in preterm infants Narendra Aladangady

Blood transfusion and intestinal perfusion in preterm infants Narendra Aladangady Blood transfusion and intestinal perfusion in preterm infants Narendra Aladangady MD, FRCPCH, PhD Consultant Neonatologist Hon Clinical Professor in Child Health History of blood transfusion First report

More information

Fluid Boluses in Preterm Babies with Poor Perfusion: A Hot Potato. Win Tin The James Cook University Hospital University of Durham

Fluid Boluses in Preterm Babies with Poor Perfusion: A Hot Potato. Win Tin The James Cook University Hospital University of Durham Fluid Boluses in Preterm Babies with Poor Perfusion: A Hot Potato Win Tin The James Cook University Hospital University of Durham Introduction Fluid Bolus/es (Intravascular Volume Expansion) - One of the

More information

Reference Values of Nocturnal Oxygenation For Use in Outpatient Oxygen Weaning Protocols in Premature Infants

Reference Values of Nocturnal Oxygenation For Use in Outpatient Oxygen Weaning Protocols in Premature Infants 47:453 459 (2012) Reference Values of Nocturnal Oxygenation For Use in Outpatient Oxygen Weaning Protocols in Premature Infants Lawrence Rhein, MD, 1,2,3 * Tregony Simoneau, MD, 1,3 Jaclyn Davis, BA, 4

More information

Guideline on the Use of Oxygen in the Newborn

Guideline on the Use of Oxygen in the Newborn Guideline on the Use of Oxygen in the Newborn Background Retinopathy of prematurity (ROP), formerly known as retrolental fibroplasia (RLF) was first described in 1942. 1 In the 1950 s reports started to

More information

1st Annual Clinical Simulation Conference

1st Annual Clinical Simulation Conference 1st Annual Clinical Simulation Conference Newborns with Acute Respiratory Distress: Diagnosis and Management Ma Teresa C. Ambat, MD Assistant Professor Division of Neonatology, Department of Pediatrics

More information

PCMCH ROP Screening Guidelines

PCMCH ROP Screening Guidelines PCMCH ROP Screening Guidelines An expert panel convened by PCMCH (the ROP Work Group) recommends the Canadian Paediatric Society s 2010 guidelines be adopted as Ontario s screening guidelines for ROP.

More information

Uses 1,2,3 : Labeled: Prevention of respiratory distress syndrome in premature infants

Uses 1,2,3 : Labeled: Prevention of respiratory distress syndrome in premature infants Brand Name: Surfaxin Generic Name: lucinactant Manufacturer 1 : Discovery Laboratories, Inc. Drug Class 2,3 : Synthetic lung surfactant Uses 1,2,3 : Labeled: Prevention of respiratory distress syndrome

More information

Adherence to oxygenation and ventilation targets in mechanically ventilated premature and sick newborns: a retrospective study

Adherence to oxygenation and ventilation targets in mechanically ventilated premature and sick newborns: a retrospective study Solberg et al. BMC Pediatrics 2013, 13:126 RESEARCH ARTICLE Open Access Adherence to oxygenation and ventilation targets in mechanically ventilated premature and sick newborns: a retrospective study Marianne

More information

Infection. Risk factor for infection ACoRN alerting sign with * Clinical deterioration. Problem List. Respiratory. Cardiovascular

Infection. Risk factor for infection ACoRN alerting sign with * Clinical deterioration. Problem List. Respiratory. Cardiovascular The ACoRN Process Baby at risk Unwell Risk factors Post-resuscitation requiring stabilization Resuscitation Ineffective breathing Heart rate < 100 bpm Central cyanosis Support Infection Risk factor for

More information